Corporate Citizenship
At Beximco Pharma, Corporate Citizenship is at the very heart of our business processes and operations. Our commitment to building a healthier tomorrow by adding value to life is based on four foundations: Patients, Community, Environment and Accountability.
Patients
Our commitment to patients remains steadfast. Beximco Pharma was the first company to launch anti-AIDS drugs (ARVs) in Bangladesh. This initiative was started in an era when known cases of AIDS-affected patients in Bangladesh were too small to be considered commercially viable. Nevertheless BPL launched five anti-AIDS drugs in 1996 and started supplying these to government and non-government organizations at cost. Today, Beximco Pharma has more than 30 registered ARV drugs in its pipeline, some of which are in the final stages of development.
The company donates a large amount of medicines to the underserved and the victims of natural disaster. Recently, Beximco Pharma made a generous donation of Tk. 10 million worth of drugs to the nationwide health camp for medical treatment of the underprivileged. Beximco Pharma regularly takes part in awareness campaigns in the form of rallies, poster presentations and seminars to observe Asthma Day, World Hypertension Day, Diabetes Day, AIDS day etc, in addition to organizing and sponsoring scientific seminars and conferences for various associations and societies in medical disciplines. Through the FRF foundation, the company has also been engaged in philanthropic activities for over a decade, providing medical consultation and diagnostic support at cost.
Beximco Pharma donates medicines to the victims of natural disasters, both national and international. For instance, drugs were donated for the victims of earthquake in Pakistan, tsunami in Sri Lanka, and cyclones SIDR in Bangladesh are a few worth mentioning.
Community
Beximco Pharma joined Mobile Alliance for Maternal Action (MAMA) in Bangladesh, an innovative coalition to use mobile phones for delivering life-saving health information to expectant and new mothers in Bangladesh. MAMA is a global alliance under which an innovative health information service has been designed in Bangladesh utilizing mobile phones to improve maternal and neonatal health outcomes. As part of the new United States Global Health Initiative, the United States Agency for International Development (USAID) has catalyzed the formation of a public-private coalition in Bangladesh to support the implementation of the service. This service is going to be available through all networks after completion of pilot. The global partners are the Johnson & Johnson, United Nations Foundation, mHealth Alliance and Baby Center.
Every year, Beximco Pharma’s internship program for undergraduate students from various academic disciplines promotes the development of professional skills. Beximco Pharma is a strong advocate of good sportsmanship and in the year under review the company sponsored a major international event – the SAF games – as well as sponsoring the national cricket league.
Environment
With global warming on the horizon, we at BPL understand the significance of protecting the environment. Beximco Pharma strives to minimize its carbon footprint and its initiatives are directed towards minimizing emissions and waste from its manufacturing operations. The company is committed to providing a safe working environment for all its employees and its Safety, Health and Environment (SHE) program is based on a framework of consistent standards. Moreover, Beximco Pharma is among the very few in the region to have proactively made the transition away from CFC-based inhalers by adopting the eco-friendly HFA formulations.
Accountability
As a public limited company we appreciate the trust of our valued shareholders and investors. Therefore, we always strive for high performance with integrity. This year Beximco Pharma achieved substantial growth, once again surpassing the industry average.
The company always strives to ensure the best utilization of funds and resources in order to maintain sustained growth and create shareholders’ wealth.